Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

Stock Information for Hoth Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.